Search
forResearch 10 of 68
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
- Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata
- A Case of Unexpected Successful Treatment of Alopecia Areata With Tralokinumab in a Patient With Atopic Dermatitis
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Biologics in the management of childhood atopic dermatitis
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Treatment of Lichen Planopilaris With Abrocitinib
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →